Medical Microbiology

diagnosis 266 – 268
rapidmethods
267 – 268
respiratorytract 632
traditionalmethod
266 – 267
urogenitaltract 635
epidemiology 268
immunity 99
infection/immunere-
sponserelationship 104
Mantouxtest 99
mortalityrates 268
prevention 268
dispositionprophy-
laxis 268
exposureprophylaxis
268
primary262, 264 – 265
pulmonary 265
secondary262,
265 – 266
sourceofinfection 268
therapy 267 , 268
transmission 268
Tuberculosisbacteria(TB)
262, 263 – 268
cellwall 264
culture 264
immunity 266
morphology 263
pathogenesis 264 – 266
seealsoMycobacterium
Tularemia 31 3, 316
diagnosis 648
Tumorimmunity 107 – 108
Tumornecrosisfactor
(TNF) 82
inmalaria 528 – 529
Tumortransformation
392, 394
carcinogenicretro-
viruses 394 – 396
DNAtumorviruses 396
Tungapenetrans(tungao-
sis) 61 8, 619 – 620
biology 619
clinicalmanifestations
620
diagnosis 62 0, 653
morphology 619
prevention 620
therapy 620
Turicellaotitidis 261
Typhoidfever280,282,
286
clinicalpicture 285
diagnosis 28 5, 639

epidemiology 287

therapy 285 – 287

seealsoSalmonellae

Typhus330,332, 613

epidemiology 331

Tyroglyphus 612

Tyrophagus 612

&U

Ulcers

acutenecroticulcerous

gingivostomatitis 631

duodenal 307 , 638

gastric 307 , 638

Ulcusmolle 303

diagnosis 637

Ureaplasmaurealyticum

228,340, 341 , 342

diagnosis 635

Urethralsyndrome 635

Urethritis292,338,339,

482

diagnosis 635

non-gonococcal(NGU)

339

Urethrocystitis292, 635

Urinarytractinfectionsee

Urogenitalinfections

Urinesampling 21 0, 623

Urogenitalinfections 295

cervicitis 636

chlamydiae336, 339

diagnosis 21 0, 62 3,

635 – 637

E.coli 292 – 293

endometritis 636

listeriosis 636

microsporidiosis 635

mycoplasmas 341

nephropathicaepidemi-

ca 461 , 635

nosocomialinfections

344

oophoritis 636

pelveoperitonitis 636

prostatitis 635

pyelonephritis 29 2, 635

salpingitis 636

schistosomiasis 636

tuberculosis 635

urethritis292,339, 4 82,

635

urethrocystitis292,

635

vaginitis(vaginosis)252,

254, 4 82, 636

venerealdiseases 637

seealsospecificdis-

eases

vulvovaginitis 36 4, 636

seealsospecificinfections

&V

Vfactor 302

Vaccination-associated

paralyticpoliomyelitis

(VAPP) 437

Vaccines 32

BCGvaccine 268

experimental 32

inactivated32, 403

liveattenuated32, 403

nakedDNAvaccine32,

403

poliomyelitis 437

purifiedmicrobialim-

munogens 32

toxoids 32

withrecombinant

viruses 403

seealsoImmunization

Vacciniavirus 426 – 429

Vaginitis(vaginosis)252,

254, 482

diagnosis 636

Vancomycin 191

mechanismofaction

198

Variantspecificsurface

antigens(VSSA) 4 86, 489

Varicella-zostervirus

(VZV) 41 8, 421 – 422

clinicalpictures 422

diagnosis 422

cutaneousinfection

650

eyeinfection 656

nervoussystem 645

epidemiology 422

pathogenesis 421

prevention 422

therapy 422

Varicellovirus 382

Variolavirus 426 – 429

diagnosis 650

Vectors 1 79, 181

bacteriophages 186

viruses 390

Venerealdiseases 637

seealsospecificdiseases

Verocytotoxins288, 294

Verrugaperuana 649

696 TTuberculosis

All rights reserved. Usage subject to terms and conditions of license

Kayser, Medical Microbiology © 2005 Thieme

All rights reserved. Usage subject to terms and conditions of license.